Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
Subscribe To Our Newsletter & Stay Updated